Date:12/12/2012

upervised by a company created by Prof. Ben-Ari and Dr. Lemonnier (Neurochlore). Analyses are also essential in order to assess the long-term effects of taking these molecules and the required dose. Lastly, the researchers stress the need to continue the work on experimental models to determine how chloride is regulated and how it is deregulated in the neural networks of autistic patients.

A patent application has been filed for this work, and a licence has been granted to the Neurochlore start-up. Neurochlore has received funding from the French National Research Agency (ANR) (in the Biomedical Innovation in public-private Research Partnership (BIRP) "Cure Autism" project).

'/>"/>

Contact: Press Office presse@inserm.fr INSERM (Institut national de la sant et de la recherche mdicale) Source:Eurekalert

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. New study identifies promising, achievable solutions to Nigerias childhood mortality crisis
2. Screening for breast cancer without X-rays: Lasers and sound merge in promising diagnostic technique
3. Stem Cell Study Shows Promising Results Against Heart Failure
4. Researchers make promising discovery in pursuit of effective lymphoma treatments
5. Diabetes drug could be a promising therapy for traumatic brain injury
6. Leukemia inhibitory factor may be a promising target against pancreatic cancer
7. Zebrafish reveal promising mechanism for healing spinal cord injury
8. Research identifies a promising new therapeutic target for aggressive breast cancer
9. Spice ingredient in curry emerges as promising basis for an Alzheimers disease medicine
10. Adalimumab is a promising therapy for children with Crohns disease
11. TB Vaccine Promising as New Way to Fight Type 1 Diabetes